Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Talking about emotions may ease unexplained pain — a trial puts it to the test

NCT ID NCT06149182

Symptom relief Sponsor: Daniel Maroti Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 27, 2026 · Last updated Jul 28, 2026 · Updated 1 time

Summary

This trial compares two types of first interviews for people with functional somatic disorders — conditions like irritable bowel syndrome or fibromyalgia where physical symptoms have no clear medical cause. One interview focuses on life stress and emotional factors, while the other is a standard psychiatric assessment. The goal is to see whether the emotion-focused interview increases patients' interest in psychological treatment and reduces their physical and psychiatric symptoms.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Life stress interview according to Emotional Awareness and Expression Therapy (EAET)
What this could lead to
If effective, this brief interview could become a low-cost way to engage patients with functional somatic disorders in psychological care and improve their symptoms.
What could go wrong
This is a small, early-stage trial comparing two interview styles, so results may not be definitive. The benefit may depend on patient willingness to engage emotionally.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

189 people

The number who actually took part.

Started

Oct 2023

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. The research subject certifies that he/she has undergone medical assessment for his/her physical symptoms. 2. The subject must have visited a physician at least three times in the last year. 3. The subject rates either moderate distress from bodily symptoms in the PHQ-15 (over 10 points) or severe distress from a single bodily symptom (at least 2 points for this symptom). 4. The research participants expresses interest in investigating whether emotional factors such as stress may contribute to symptoms. 5. Research subjects either affirm the presence of emotionally difficult life events (affirm at least 1 such event in the ACE-10 or reach the proposed cut-off point of 21p in the PCL-5). 6. Drugs used should have been stable for at least 1 month. Exclusion Criteria: 1. Research subjects suffer from ongoing substance abuse (alcohol or drugs) or are deemed to have serious mental illness (psychotic illness, suicidal ideation, antisocial personality disorder etc). 2. The research subjects have ongoing medication of a clearly addictive and sedative nature (e.g. benzodiazipines). 3. The research subject participates in other psychological treatment focusing on physical symptoms. However, other psychological treatment is allowed where the support therapy does not take place more often than once a month. 4. The research subject does not master the Swedish language sufficiently to be able to assimilate written material in Swedish.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Functional somatic disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

somatization disorder somatoform disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Functional somatic disorder Somatic symptom disorder

Contacts and locations

Locations

  • Stockholm University

    Stockholm, 10691, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.